Authors


Frédéric Kahn

Latest:

I Saw the Future of Global Pharmaceutical Production in India

Guest contributor Frederic Kahn discusses the state of the Indian pharmaceutical manufacturing industry.



Cliff Campbell

Latest:

Quality Quartets in Risk-Based Qualification:

Quality Quartets may be used to achieve knowledge-driven, risk-based approaches to commissioning and qualification that are consistent with ICH Q9(R1) principles.


SCIEX

Latest:

Is “right first time, every time” a pipedream for metabolite identification by LC-MS?

The dream state If we lived in an ideal world, it would be possible to unambiguously identify metabolites using a single analytical experiment. This analytical technique would need to be efficient and easily generate the information needed from a routine assay that is also robust, enabling confident decision-making during drug discovery. At SCIEX, we believe that metabolite identification using the ZenoTOF 7600 system gets close to this dream state.


Beverly Schad

Latest:

Coating and Taste Masking with Shellac

The authors describe the background and applications of fully formulated aqueous shellac for film-coating systems.



Naomi Kruhlak

Latest:

Master File Submission of Structures

The SD File format offers benefits for KASA and cheminformatics to support regulatory submissions.


Thierry Gastineau

Latest:

Industry 1VQ Solutions: Change of Lot or Extension of Shelf-life of Reference Standard

Change of lot or extension of reference standard shelf-life is considered low risk and should be downgraded from prior-approval to being managed in the Pharmaceutical Quality System (PQS) only based on a science and risk-based approach.


A. Mathur

Latest:

Dielectric Spectroscopy: Choosing the Right Approach

This tutorial paper is meant to aid in dielectric-sensor selection


Purolite

Latest:

Interview with Hayley Crowe, Executive VP & GM at Ecolab Global Life Sciences

Hayley Crowe, Executive VP & GM at Ecolab Global Life Sciences, talks about the company's services and how they relate to trends in bioprocessing and purification.


Subrata Chakraborty

Latest:

Intervention Risk Evaluation and Management in Aseptic Manufacturing–Part II

IREM can be used for effectively assessing and mitigating risks and improving the overall sterility assurance level in all types of aseptic processing lines.


Andreas Mangel

Latest:

Sterile Production According To The New EU GMP Annex 1: A Focus On Capping

The recent amendment to Annex 1 has seen controversial changes relating to the capping of vials.


J. Martínez Calatayud 

Latest:

Obtaining simultaneous multiple dissolution profiles of solid oral dosage formulations

Testing the dissolution rates of a pharmaceutical formulation (also known as in vitro availability) aids drug quality control and is a compulsory requirement of the British, European and US pharmacopoeias.


Shahid Manzur

Latest:

Best Practices for Pharma Manufacturing Quality Teams

Automated systems help detect and resolve quality issues.


Umit Kartoglu

Latest:

QRM, Knowledge Management, and the Importance of ICH Q9(R1)

This paper reflects upon the past 15 years of experience in the application of QRM and KM within the pharmaceutical GMP environment.


Timothy Schofield

Latest:

Reducing Uncertainty of an Analytical Method through Efficient Use of Replication

A well-chosen replication strategy can effectively reduce the uncertainty for an analytical method, enabling appropriate decisions regarding pharmaceutical quality.


Robert Thomas

Latest:

ACS-Grade Reagents’ Database Launched

The complete online database of ACS Reagent Chemicals is now available.



Edmont Stoyanov 

Latest:

An All-Round Excipient For Direct Compression

Using new co-processing technologies, the authors show that it is possible to formulate an 'all-round' excipient.


Pietro Forgione

Latest:

Accelerating Time-to-Insight Throughout the BioPharma Lifecycle

Innovation is driven through a strong digital backbone.



Jo Smewing

Latest:

Table Testing Techniques

The rising popularity of fast dissolving, immediate-release dosage forms can be attributed to their convenience and ease of administration.


Christian Goesker

Latest:

How Integrated Project Delivery Enables Speed: A Phase-By-Phase Guide

By eliminating the waste involved in traditional approaches to project set-up and execution, integrated project delivery helps innovators in the European life sciences market meet their fast-track delivery targets.


Houston Smith

Latest:

Coating and Taste Masking with Shellac

The authors describe the background and applications of fully formulated aqueous shellac for film-coating systems.


Bill Connell

Latest:

Build CMO Relationships with Effective Management Practices

Contract service providers offer vital services to bio/pharma companies of all sizes. Establishing an effective working relationship and managing operations are key to avoiding compliance issues.


Lokesh Kumar

Latest:

Variables Affecting Reconstitution Time of Dry Powder for Injection

The authors describe the factors affecting reconstitution time of dry powder for injection and classifies them as intrinsic and extrinsic parameters.


Sunday Ndiana-Abasi

Latest:

Evaluating Okra Gum in a Floating Tablet Formulation as a Novel Drug Delivery System

The potential for okra gum as a polymer candidate for new oral drug formulations was evaluated.


Salavadi S. Easwaran

Latest:

The Pros And Cons Of Single-Use Systems

The willingness of the industry to use single-use bioreactors is currently influenced by the criticality of the step, the value of the product and the time for product development and production.


Paulien Ravenstijn

Latest:

Extrapolating Data from Adult Clinical Trials to Advance Pediatric Drug Development

Extrapolating data from adult clinical trials to a pediatric population is a proven method to avoid unnecessary pediatric clinical trials. Representatives of the Pediatric Working Group of the IQ Consortium share case studies that demonstrate how adult clinical trial data can be used to support the dose selection and regimen—or waive the need for a placebo control arm—for pediatric studies.


Gaylord

Latest:

Evaluation of Procipient ®(Dimethyl Sulfoxide USP, PhEur ) in Topical Dosage Form Formulations

Procipient ® (Dimethyl Sulfoxide USP, PhEur ) is the only compendial DMSO specifically for pharmaceutical use. Procipient is supported with the proper documentation required by pharmaceutical regulatory authorities.